Health technology assessment (HTA) in England, France and Germany: what do matched drug pairs tell us about recommendations by national HTA agencies?

Schaefer R, Hernandez D, Selberg L, Schlander M

Open source

DOI
10.2217/cer-2021-0047
Published
2021 Nov
Container
Journal of comparative effectiveness research
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.2217/cer-2021-0047,
  title = {Health technology assessment (HTA) in England, France and Germany: what do matched drug pairs tell us about recommendations by national HTA agencies?},
  author = {Schaefer R and Hernandez D and Selberg L and Schlander M},
  year = {2021},
  journal = {Journal of comparative effectiveness research},
  doi = {10.2217/cer-2021-0047},
  url = {https://doi.org/10.2217/cer-2021-0047}
}

RIS

TY  - JOUR
TI  - Health technology assessment (HTA) in England, France and Germany: what do matched drug pairs tell us about recommendations by national HTA agencies?
AU  - Schaefer R
AU  - Hernandez D
AU  - Selberg L
AU  - Schlander M
PY  - 2021
JO  - Journal of comparative effectiveness research
DO  - 10.2217/cer-2021-0047
UR  - https://doi.org/10.2217/cer-2021-0047
ER  - 

APA

R, S., D, H., L, S., & M, S. (2021). Health technology assessment (HTA) in England, France and Germany: what do matched drug pairs tell us about recommendations by national HTA agencies?. Journal of comparative effectiveness research. https://doi.org/10.2217/cer-2021-0047

Source records